Abstract
HLA markers for susceptibility and expression in scleroderma.
Dafna D Gladman, Tabitha N Kung, Fotios Siannis, Fawnda Pellett, Vernon T Farewell and Peter Lee
The Journal of Rheumatology August 2005, 32 (8) 1481-1487;
Dafna D Gladman
Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Ontario, Canada. dafna.gladman@utoronto.ca
Tabitha N Kung
Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Ontario, Canada. dafna.gladman@utoronto.ca
Fotios Siannis
Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Ontario, Canada. dafna.gladman@utoronto.ca
Fawnda Pellett
Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Ontario, Canada. dafna.gladman@utoronto.ca
Vernon T Farewell
Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Ontario, Canada. dafna.gladman@utoronto.ca
Peter Lee
Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Ontario, Canada. dafna.gladman@utoronto.ca
In this issue
HLA markers for susceptibility and expression in scleroderma.
Dafna D Gladman, Tabitha N Kung, Fotios Siannis, Fawnda Pellett, Vernon T Farewell, Peter Lee
The Journal of Rheumatology Aug 2005, 32 (8) 1481-1487;